Salute e Benessere

Institute for TCIM/CAM to organize World Health Congress 2023 in Prague

The world leading experts in TCIM and conventional medicine will share their healthcare experience. They will present a wide range of holistic healthcare where TCIM/CAM (traditional complementary, integrative and alternative medicine) disciplines are involved. The world leading experts in TCIM and conventional medicine will share their healthcare experience. They will present a wide range of holistic healthcare where TCIM/CAM (traditional complementary, integrative and alternative medicine)...
PR Newswire
15/05/2023

Optimum Hires Senior Journalist Stephen Adams, Former Medical Editor of The Mail…

Commenting on the appointment, Mary Clark, Chief Executive Officer of Optimum Strategic Communications, said: "After an illustrious career in journalism, we are very pleased that Stephen has joined the Optimum team. It is critical that healthcare and life sciences companies can communicate a compelling narrative. Stephen's extensive knowledge of medical and healthcare issues, combined with his superb writing and content generation skills, will be invaluable as we provide intelligent and…
PR Newswire
15/05/2023

Alvotech Issues Annual Equality Report Covering 2022

Alvotech's global workforce is now evenly split between females and males, and the unexplained gender pay gap has been reduced to 1.6% from 5.2% in December 2020Alvotech's Equality Policy, which is based on Icelandic law, has been implemented for the workforce globallyAlvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the release of its second annual Equality Report covering...
Nasdaq GlobeNewswire
15/05/2023

MGI Empowers the Completion of Nearly 60,000 Samples for The Million Microbiome…

"Countless studies have highlighted the importance of the microbiome in human health and disease. Yet, our knowledge of the composition of the microbiome in different parts of the body across countries, ages, sexes, and in relation to human health and disease remains limited," said Duncan Yu, President of MGI. "Through MMHP, we are pushing forward microbial metagenomic research while empowering researchers within the microbiology community with access to MGI's innovative…
PR Newswire
15/05/2023

FDI World Dental Federation's Virtual Summit ON WORLD ENVIRONMENT DAY TO…

"The strides we have made through this initiative are truly commendable, particularly the development of the Consensus Statement on Environmentally Sustainable Oral Healthcare," stated Prof. Ihsane Ben Yahya, FDI President. "I am excited to continue our journey towards sustainability to ensure a healthy future for our patients, our profession and our planet." "The strides we have made through this initiative are truly commendable, particularly the development of…
PR Newswire
15/05/2023

Acesion Pharma Announces Positive Pre-Clinical Data for AP31969

To refine drug proarrhythmia risk prediction; regulators, academics, and industry have collaborated on developing pre-clinical models with this specific purpose. In two such models, AP31969 has demonstrated a low risk of proarrhythmia with robust differentiation to existing drugs, which have a high risk of proarrhythmia, tested in the same models. Further results from pre-clinical studies showed that AP31969, tested at expected supratherapeutic doses across two in-vivo large animal models, has…
PR Newswire
15/05/2023

Invitation to presentation of Sectra's year-end report 2022/2023

Participation will take place via Microsoft Teams. Questions can be posed using the chat function or by sending questions in advance via email to info.investor@sectra.com. Participation will take place via Microsoft Teams. Questions can be posed using the chat function or by sending questions in advance via email toinfo.investor@sectra.com. To participate, follow the instructions oninvestor.sectra.com/q4report2223. The broadcast will be made available on the same webpage after the...
PR Newswire
15/05/2023

Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite…

NT-proBNP Assay Now Available with Age-Based Cutoffs and Comorbidity Data NT-proBNP Assay Now Available with Age-Based Cutoffs and Comorbidity Data ROME,May 15, 2023/PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, today unveiled the DxI 9000 Access Immunoassay Analyzer, the most productive immunoassay analyzer per footprint. The DxI 9000 Analyzer can run up to 215 tests per hour per square meter (tests/hr/m 2 ). The DxI 9000 Analyzer innovations address today's...
PR Newswire
15/05/2023

Fertility Counts: Merck Launch New Initiative to Underscore the Importance of…

"The trends we are seeing in fertility across the Asia-Pacific region will have long-term effects on all parts of society – the economy, the healthcare system, and on how the elderly are cared for in the future," said Professor Kamthorn Pruksananonda, Chairman of Reproductive Medicine at the Royal Thai College of Obstetricians and Gynaecologists. "We now need to seriously explore policy solutions that enable and support people who want to have children, in order to address the…
PR Newswire
15/05/2023

New Sandoz Board of Directors appointed

Novartis Board of Directors approves the recommendation of Sandoz Chairman-designate for the future Sandoz Board of Directors, to start preparatory work in June, followed by formal constitution in H2 2023 Experienced and diverse group of corporate leaders with a track record of growing businesses and driving value for the organization and society will help set strategic direction for Sandoz and support its future development Basel, May 15, 2023— Sandoz takes the next steps to...
Nasdaq GlobeNewswire
15/05/2023

Dualyx raises €40 million to progress Treg therapies for autoimmune diseases…

Dualyxraises €40 million to progress Treg therapies for autoimmune diseases into the clinic Use of proceeds will enable the development of the Company's lead autoimmune program DT-001,targeting TNFR2 , as well as its pipeline of Treg candidatesFinancing co-led by Fountain Healthcare Partners, Forbion and AnderaPartners with support from existing investorsBernard Coulie appointed as Independent Chairman with immediate effect...
Nasdaq GlobeNewswire
15/05/2023

BioSenic to host Annual General Meeting on June 14 2023

REGULATED INFORMATION Preliminary documents for the Annual General Meeting have been made available on company's websiteMont-Saint-Guibert, Belgium, May 15th , 2023 7 .00am CET – BioSenic (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious autoimmune and inflammatory diseases and cell repair, invites its shareholders and the holders of registered subscription rights and registered convertible bonds of the Company to the Annual...
Nasdaq GlobeNewswire
15/05/2023

Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and…

"We are looking forward to partnering with Keymed to jointly discover and develop transformative RNA therapeutics globally," said Stella SHI, the founder and CEO of Rona. "Rona's proprietary next generation siRNA platform technology and the advanced biology expertise from Keymed is a strategic fit for developing first-in-class siRNA therapeutic for devastating diseases like glomerulonephritis." "We are looking forward to partnering with Keymed to jointly discover and…
PR Newswire
15/05/2023

Transactions in Zealand Pharma shares and/or related securities by persons…

Company announcement – No. 21 / 2023 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, May 12, 2023–Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's shares or...
Nasdaq GlobeNewswire
12/05/2023

Information on the Total Number of Voting Rights (Denominator) following…

Regulated Information - Denominator Atlas Special Opportunities, LLChas converted 12convertible bonds in Oxurion resulting in a EUR 300 ,000capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5billion.Leuven, BELGIUM ,Boston, MA, US–...
Nasdaq GlobeNewswire
12/05/2023

Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC…

Regulated Information Leuven, BELGIUM, Boston, MA, US – May 12 , 2023 – 7 .00 PM CETOxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation 1it has receivedtransparency notifications as follows: Oxurion received a transparency notification on May 8, 2023, from...
Nasdaq GlobeNewswire
12/05/2023

Life Science Instrumentation Market worth $73.9 billion | MarketsandMarkets

Life Science Instrumentation Market in terms of revenue was estimated to be worth $54.9 billion in 2023 and is poised to reach $73.9 billion by 2028, growing at a CAGR of 6.1% from 2023 to 2028 according to a new report by MarketsandMarkets™. The major factors driving the growth of this market include growing food safety concerns, rising investments in pharmaceutical R&D, increasing public-private investments, and lucrative opportunities in emerging markets. Life Science Instrumentation...
PR Newswire
12/05/2023

Sun Nuclear Showcases Evolving and Expanding Quality Management Portfolio at…

On Sunday, May 14, Sun Nuclear will hold its annual lunch symposium, featuring insights from leaders in the field of Radiation Therapy. During the symposium, Rhydian Caines, M.Sc., of The Clatterbridge Cancer Centre NHS Foundation Trust (Liverpool, United Kingdom) will present on his centre's experience using the SunCHECK® Platform, including highlights from his ESTRO abstract, When no news is good news: commercial automated EPID in vivo dosimetry deployed as a safety check.1 The abstract aims…
PR Newswire
12/05/2023

Major shareholder announcement

Company announcement Orphazyme A/SNo. 06/2023 Ole Maaløes Vej 3 DK-2200 Copenhagen N...
Nasdaq GlobeNewswire
12/05/2023

Monthly information related to total number of voting rights and shares…

Monthly information related to total number of voting rights and shares composing the share capital _April 30 , 2023 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – FranceListing markets:Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) &Nasdaq Global Select Market in the United-States (Symbol : ERYP) Website : www.erytech.com DateTotal of shares...
Nasdaq GlobeNewswire
12/05/2023

Mithra Pharmaceuticals - Payment of the interests of the Highbridge/Whitebox…

Payment of the interests of the Highbridge/Whitebox loans Information on the total number of voting rights (denominator) Liege, Belgium, 12May 2023 – 17:50 CET– Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the " Company " or " Mithra "), a company dedicated to Women's Health, today announces that, the third quarterly interests of the loan facility concluded with funds managed by Highbridge Capital Management, LLC (" Highbridge ") and funds managed by…
Nasdaq GlobeNewswire
12/05/2023

Press release Biocartis Group NV: Results of the Annual Shareholders' Meeting…

PRESS RELEASE: REGULATED INFORMATION 12 May 2023, 17:40 CEST Results of the Annual Shareholders' Meeting held on12 May2023 Mechelen, Belgium, 12 May 2023– Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company (Euronext Brussels: BCART), held its annual shareholders' meeting today at its offices in Mechelen, Belgium.The shareholders approved all items on the agenda, with the exception of the agenda item regarding the approval of...
Nasdaq GlobeNewswire
12/05/2023

Infectious Disease And Molecular Diagnostics Conference: Bringing Together…

One of the key highlights of the conference is the opportunity for international speakers to share their insights and expertise on various topics related to infectious disease and molecular diagnostics. The event offers an excellent platform for thought leaders to showcase their research and discuss their findings with a diverse audience. One of the key highlights of the conference is the opportunity for international speakers to share their insights and expertise on various topics related to...
PR Newswire
12/05/2023

Disclosure of voting rights at AGM in Vistin Pharma ASA

In relation to the Annual General Meeting in Vistin Pharma ASA on the 22nd of May, the Company's Chair of the Board, Øyvin Brøymer, has received open proxies to represent a total of 3 905 611 shares in the Company at the AGM, corresponding to 8.81% of the total number of votes and shares in the Company. Together with the 12 575 000 shares held by Øyvin Brøymer through Intertrade Shipping AS, he will represent a total of 16 480 611 votes at the AGM, corresponding to a total of 37,16% of the...
Nasdaq GlobeNewswire
12/05/2023